,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,337950,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5682,PSMA1,https://ctdbase.org/detail.go?type=gene&acc=5682,,,5682,PSMA1,9606,Homo sapiens (human),Valproic acid results in decreased methylation of PSMA1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
1,425320,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26227,PHGDH,https://ctdbase.org/detail.go?type=gene&acc=26227,,,26227,PHGDH,9606,Homo sapiens (human),Valproic acid results in decreased methylation of PHGDH gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
2,456463,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,23120,ATP10B,https://ctdbase.org/detail.go?type=gene&acc=23120,,,23120,ATP10B,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of ATP10B mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
3,456464,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,23250,ATP11A,https://ctdbase.org/detail.go?type=gene&acc=23250,,,23250,ATP11A,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of ATP11A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
4,456465,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,57130,ATP13A1,https://ctdbase.org/detail.go?type=gene&acc=57130,,,57130,ATP13A1,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of ATP13A1 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
5,456466,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,79572,ATP13A3,https://ctdbase.org/detail.go?type=gene&acc=79572,,,79572,ATP13A3,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of ATP13A3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
6,456467,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,84239,ATP13A4,https://ctdbase.org/detail.go?type=gene&acc=84239,,,84239,ATP13A4,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of ATP13A4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
7,528033,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,54961,SSH3,https://ctdbase.org/detail.go?type=gene&acc=54961,,,54961,SSH3,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SSH3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
8,528034,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,8082,SSPN,https://ctdbase.org/detail.go?type=gene&acc=8082,,,8082,SSPN,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SSPN mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SSPN mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SSPN mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
9,528035,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6751,SSTR1,https://ctdbase.org/detail.go?type=gene&acc=6751,,,6751,SSTR1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of SSTR1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in decreased expression of SSTR1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
10,528036,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,29101,SSU72,https://ctdbase.org/detail.go?type=gene&acc=29101,,,29101,SSU72,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SSU72 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SSU72 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
11,528037,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,283687,ST20-AS1,https://ctdbase.org/detail.go?type=gene&acc=283687,,,283687,ST20-AS1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ST20-AS1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
12,528038,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6484,ST3GAL4,https://ctdbase.org/detail.go?type=gene&acc=6484,,,6484,ST3GAL4,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of ST3GAL4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
13,456461,4055,Comparative Toxicogenomics Database (CTD),Menadione,D024483,Vitamin K 3,https://ctdbase.org/detail.go?type=chem&acc=D024483,11273,ATXN2L,https://ctdbase.org/detail.go?type=gene&acc=11273,,,11273,ATXN2L,9606,Homo sapiens (human),Vitamin K 3 affects the expression of ATXN2L mRNA,,,PMID:20044591,https://www.ncbi.nlm.nih.gov/pubmed/20044591,20044591,,
14,456462,4055,Comparative Toxicogenomics Database (CTD),Menadione,D024483,Vitamin K 3,https://ctdbase.org/detail.go?type=chem&acc=D024483,549,AUH,https://ctdbase.org/detail.go?type=gene&acc=549,,,549,AUH,9606,Homo sapiens (human),Vitamin K 3 affects the expression of AUH mRNA,,,PMID:20044591,https://www.ncbi.nlm.nih.gov/pubmed/20044591,20044591,,
15,425822,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,3675,ITGA3,https://ctdbase.org/detail.go?type=gene&acc=3675,,,3675,ITGA3,9606,Homo sapiens (human),Methapyrilene results in decreased methylation of ITGA3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
16,425823,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,3678,ITGA5,https://ctdbase.org/detail.go?type=gene&acc=3678,,,3678,ITGA5,9606,Homo sapiens (human),Methapyrilene results in increased methylation of ITGA5 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
17,527249,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,561287,F13A1B,https://ctdbase.org/detail.go?type=gene&acc=561287,,,561287,f13a1b,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of F13A1B mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
18,527250,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,2149,F2R,https://ctdbase.org/detail.go?type=gene&acc=2149,,,2149,F2R,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of F2R mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
19,527251,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,2157,F8,https://ctdbase.org/detail.go?type=gene&acc=2157,,,2157,F8,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of F8 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
20,527252,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,91442,FAAP24,https://ctdbase.org/detail.go?type=gene&acc=91442,,,91442,FAAP24,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of FAAP24 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
21,527253,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,91442,FAAP24,https://ctdbase.org/detail.go?type=gene&acc=91442,,,91442,FAAP24,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of FAAP24 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
22,527254,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,2171,FABP5,https://ctdbase.org/detail.go?type=gene&acc=2171,,,2171,FABP5,9606,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of FABP5 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
23,527255,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,9415,FADS2,https://ctdbase.org/detail.go?type=gene&acc=9415,,,9415,FADS2,9606,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of FADS2 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
24,527256,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,3995,FADS3,https://ctdbase.org/detail.go?type=gene&acc=3995,,,3995,FADS3,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of FADS3 mRNA,,,PMID:21527772,https://www.ncbi.nlm.nih.gov/pubmed/21527772,21527772,,
25,534451,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,2589,GALNT1,https://ctdbase.org/detail.go?type=gene&acc=2589,,,2589,GALNT1,9606,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of GALNT1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
26,337947,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,57575,PCDH10,https://ctdbase.org/detail.go?type=gene&acc=57575,,,57575,PCDH10,9606,Homo sapiens (human),Entinostat results in increased expression of PCDH10 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
27,337948,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,57575,PCDH10,https://ctdbase.org/detail.go?type=gene&acc=57575,,,57575,PCDH10,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
28,337949,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,27253,PCDH17,https://ctdbase.org/detail.go?type=gene&acc=27253,,,27253,PCDH17,9606,Homo sapiens (human),Entinostat results in decreased expression of PCDH17 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
29,456641,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,9282,MED14,https://ctdbase.org/detail.go?type=gene&acc=9282,,,9282,MED14,9606,Homo sapiens (human),Entinostat results in increased expression of MED14 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
30,456642,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,9282,MED14,https://ctdbase.org/detail.go?type=gene&acc=9282,,,9282,MED14,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED14 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
31,456819,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,84466,MEGF10,https://ctdbase.org/detail.go?type=gene&acc=84466,,,84466,MEGF10,9606,Homo sapiens (human),Entinostat results in increased expression of MEGF10 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
32,456820,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,84466,MEGF10,https://ctdbase.org/detail.go?type=gene&acc=84466,,,84466,MEGF10,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEGF10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
33,456821,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,254528,MEIOB,https://ctdbase.org/detail.go?type=gene&acc=254528,,,254528,MEIOB,9606,Homo sapiens (human),Entinostat results in increased expression of MEIOB mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
34,456822,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,284071,MEIOC,https://ctdbase.org/detail.go?type=gene&acc=284071,,,284071,MEIOC,9606,Homo sapiens (human),Entinostat results in increased expression of MEIOC mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
35,456823,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,4211,MEIS1,https://ctdbase.org/detail.go?type=gene&acc=4211,,,4211,MEIS1,9606,Homo sapiens (human),Entinostat results in decreased expression of MEIS1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
36,525076,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385,CREB1,9606,Homo sapiens (human),Nifedipine inhibits the reaction [[potassium chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein]|nifedipine inhibits the reaction [potassium chloride results in increased phosphorylation of CREB1 protein],,,PMID:20128810,https://www.ncbi.nlm.nih.gov/pubmed/20128810,20128810,,
37,525077,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385,CREB1,10116,Rattus norvegicus (Norway rat),Nifedipine inhibits the reaction [nicotine results in increased phosphorylation of CREB1 protein],,,PMID:21113126,https://www.ncbi.nlm.nih.gov/pubmed/21113126,21113126,,
38,525078,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1434,CSE1L,https://ctdbase.org/detail.go?type=gene&acc=1434,,,1434,CSE1L,9606,Homo sapiens (human),Nifedipine inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of CSE1L protein],,,PMID:19556728,https://www.ncbi.nlm.nih.gov/pubmed/19556728,19556728,,
39,525079,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1447,CSN2,https://ctdbase.org/detail.go?type=gene&acc=1447,,,1447,CSN2,10090,Mus musculus (house mouse),Nifedipine promotes the reaction [cadmium results in decreased expression of CSN2 mrna]|nifedipine results in decreased expression of CSN2 mRNA,,,PMID:21167921,https://www.ncbi.nlm.nih.gov/pubmed/21167921,21167921,,
40,525080,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,2017,CTTN,https://ctdbase.org/detail.go?type=gene&acc=2017,,,2017,CTTN,9606,Homo sapiens (human),Nifedipine inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of CTTN protein],,,PMID:19556728,https://www.ncbi.nlm.nih.gov/pubmed/19556728,19556728,,
41,525081,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),[nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CXCL8 mrna],,,PMID:18938131,https://www.ncbi.nlm.nih.gov/pubmed/18938131,18938131,,
42,525082,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),Nifedipine inhibits the reaction [nickel chloride results in increased expression of CXCL8 mrna],,,PMID:25045119,https://www.ncbi.nlm.nih.gov/pubmed/25045119,25045119,,
43,525083,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1585,CYP11B2,https://ctdbase.org/detail.go?type=gene&acc=1585,,,1585,CYP11B2,10026,Cricetinae (hamsters),Nifedipine inhibits the reaction [potassium results in increased expression of CYP11B2 mrna]|nifedipine inhibits the reaction [colforsin results in increased expression of CYP11B2 mrna],,,PMID:9888551,https://www.ncbi.nlm.nih.gov/pubmed/9888551,9888551,,
44,525925,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576,CYP3A4,9606,Homo sapiens (human),Troleandomycin inhibits the reaction [CYP3A4 protein results in increased oxidation of nifedipine],,,PMID:20863320,https://www.ncbi.nlm.nih.gov/pubmed/20863320,20863320,,
45,525926,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576,CYP3A4,9606,Homo sapiens (human),YM 758 inhibits the reaction [CYP3A4 protein results in increased metabolism of nifedipine],,,PMID:19230594,https://www.ncbi.nlm.nih.gov/pubmed/19230594,19230594,,
46,525927,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576,CYP3A4,10090,Mus musculus (house mouse),Nifedipine results in decreased activity of CYP3A4 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
47,525928,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576,CYP3A4,10116,Rattus norvegicus (Norway rat),[SOD2 co-treated with CYP3A4] affects the susceptibility to nifedipine,,,PMID:19501153,https://www.ncbi.nlm.nih.gov/pubmed/19501153,19501153,,
48,527858,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617,PRL,10116,Rattus norvegicus (Norway rat),"Nifedipine inhibits the reaction [estradiol results in increased secretion of PRL protein]|nifedipine inhibits the reaction [dieldrin results in increased secretion of PRL protein]|nifedipine inhibits the reaction [bisphenol A results in increased secretion of PRL protein]|nifedipine inhibits the reaction [nonylphenol results in increased secretion of PRL protein]|nifedipine inhibits the reaction [o,p'-DDT results in increased secretion of PRL protein]",,,PMID:15811834,https://www.ncbi.nlm.nih.gov/pubmed/15811834,15811834,,
49,527859,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617,PRL,10116,Rattus norvegicus (Norway rat),Nifedipine inhibits the reaction [coumestrol results in increased secretion of PRL protein]|nifedipine inhibits the reaction [diethylstilbestrol results in increased secretion of PRL protein]|nifedipine inhibits the reaction [endosulfan results in increased secretion of PRL protein],,,PMID:15811834|PMID:17174995,https://www.ncbi.nlm.nih.gov/pubmed/15811834|https://www.ncbi.nlm.nih.gov/pubmed/17174995,15811834|17174995,,
50,527860,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9606,Homo sapiens (human),[nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of PTGS2 mrna],,,PMID:18938131,https://www.ncbi.nlm.nih.gov/pubmed/18938131,18938131,,
51,527861,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9606,Homo sapiens (human),Nifedipine inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of PTGS2 mrna],,,PMID:18388244,https://www.ncbi.nlm.nih.gov/pubmed/18388244,18388244,,
52,527862,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10090,Mus musculus (house mouse),Arachidonyltrifluoromethane promotes the reaction [nifedipine inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of PTGS2 mrna]]|nifedipine inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of PTGS2 mrna],,,PMID:19063610,https://www.ncbi.nlm.nih.gov/pubmed/19063610,19063610,,
53,527863,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10116,Rattus norvegicus (Norway rat),Nifedipine inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of PTGS2 mrna],,,PMID:23583884,https://www.ncbi.nlm.nih.gov/pubmed/23583884,23583884,,
54,527864,4485,Comparative Toxicogenomics Database (CTD),Nifedipine,D009543,Nifedipine,https://ctdbase.org/detail.go?type=chem&acc=D009543,5741,PTH,https://ctdbase.org/detail.go?type=gene&acc=5741,,,5741,PTH,9913,Bos taurus (cattle),"Nifedipine inhibits the reaction [PTH protein results in increased uptake of cadmium]|nifedipine inhibits the reaction [3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester promotes the reaction [PTH protein results in increased uptake of cadmium]]",,,PMID:7524195,https://www.ncbi.nlm.nih.gov/pubmed/7524195,7524195,,
55,525743,4494,DrugBank,Nilvadipine,DB06712,Nilvadipine,https://www.drugbank.ca/drugs/DB06712,BE0008716,Voltage-dependent T-type calcium channel subunit alpha-1G,https://www.drugbank.ca/bio_entities/BE0008716,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,8913,CACNA1G,9606,Homo sapiens (human),Inhibitor,,,PMID:16398057,https://www.ncbi.nlm.nih.gov/pubmed/16398057,16398057,,
56,554877,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[LM-1685 co-treated with carboxyamido-triazole] results in increased cleavage of PARP1 protein],,,PMID:15867384,https://www.ncbi.nlm.nih.gov/pubmed/15867384,15867384,,
57,527680,4735,Comparative Toxicogenomics Database (CTD),Pentamidine,D010419,Pentamidine,https://ctdbase.org/detail.go?type=chem&acc=D010419,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576,CYP3A4,9606,Homo sapiens (human),Pentamidine results in decreased activity of CYP3A4 protein,,,PMID:11124226,https://www.ncbi.nlm.nih.gov/pubmed/11124226,11124226,,
58,414513,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,729533,FAM72A,https://ctdbase.org/detail.go?type=gene&acc=729533,,,729533,FAM72A,10090,Mus musculus (house mouse),NR1I3 protein affects the reaction [phenobarbital results in increased expression of FAM72A mrna]|phenobarbital results in increased expression of FAM72A mRNA,,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
59,414514,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,729533,FAM72A,https://ctdbase.org/detail.go?type=gene&acc=729533,,,729533,FAM72A,10090,Mus musculus (house mouse),Phenobarbital affects the expression of FAM72A mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
60,414515,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,145773,FAM81A,https://ctdbase.org/detail.go?type=gene&acc=145773,,,145773,FAM81A,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of FAM81A mRNA,,,PMID:19270015,https://www.ncbi.nlm.nih.gov/pubmed/19270015,19270015,,
61,414516,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,113828,FAM83F,https://ctdbase.org/detail.go?type=gene&acc=113828,,,113828,FAM83F,10090,Mus musculus (house mouse),Phenobarbital affects the expression of FAM83F mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
62,481496,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,6337,SCNN1A,https://ctdbase.org/detail.go?type=gene&acc=6337,,,6337,SCNN1A,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of SCNN1A mrna|nr1i3 protein affects the reaction [phenobarbital results in decreased expression of SCNN1A mrna],,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
63,481497,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,6337,SCNN1A,https://ctdbase.org/detail.go?type=gene&acc=6337,,,6337,SCNN1A,10116,Rattus norvegicus (Norway rat),Phenobarbital results in increased expression of SCNN1A mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
64,492905,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792,NFKBIA,10116,Rattus norvegicus (Norway rat),Phenobarbital affects the expression of NFKBIA mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
65,492906,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,4794,NFKBIE,https://ctdbase.org/detail.go?type=gene&acc=4794,,,4794,NFKBIE,9606,Homo sapiens (human),Phenobarbital affects the expression of NFKBIE mRNA,,,PMID:19159669,https://www.ncbi.nlm.nih.gov/pubmed/19159669,19159669,,
66,492907,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,4794,NFKBIE,https://ctdbase.org/detail.go?type=gene&acc=4794,,,4794,NFKBIE,10090,Mus musculus (house mouse),Phenobarbital affects the expression of NFKBIE mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
67,492908,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,64332,NFKBIZ,https://ctdbase.org/detail.go?type=gene&acc=64332,,,64332,NFKBIZ,10090,Mus musculus (house mouse),Phenobarbital affects the expression of NFKBIZ mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
68,493062,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,374354,NHLRC2,https://ctdbase.org/detail.go?type=gene&acc=374354,,,374354,NHLRC2,10090,Mus musculus (house mouse),Phenobarbital affects the expression of NHLRC2 mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
69,493063,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,55651,NHP2,https://ctdbase.org/detail.go?type=gene&acc=55651,,,55651,NHP2,10090,Mus musculus (house mouse),Phenobarbital affects the expression of NHP2 mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
70,493064,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,64855,NIBAN2,https://ctdbase.org/detail.go?type=gene&acc=64855,,,64855,NIBAN2,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of NIBAN2 mRNA,,,PMID:19270015,https://www.ncbi.nlm.nih.gov/pubmed/19270015,19270015,,
71,493065,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,64855,NIBAN2,https://ctdbase.org/detail.go?type=gene&acc=64855,,,64855,NIBAN2,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of NIBAN2 mRNA,,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
72,493066,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,4811,NID1,https://ctdbase.org/detail.go?type=gene&acc=4811,,,4811,NID1,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with phenobarbital] results in increased expression of NID1 mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
73,493067,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,4811,NID1,https://ctdbase.org/detail.go?type=gene&acc=4811,,,4811,NID1,10090,Mus musculus (house mouse),NR1I3 protein affects the reaction [phenobarbital results in increased expression of NID1 mrna]|phenobarbital results in increased expression of NID1 mRNA,,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
74,456643,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059,DNM1L,10116,Rattus norvegicus (Norway rat),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in increased expression of DNM1L mRNA",,,PMID:29128369,https://www.ncbi.nlm.nih.gov/pubmed/29128369,29128369,,
75,456644,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,1874,E2F4,https://ctdbase.org/detail.go?type=gene&acc=1874,,,1874,E2F4,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in increased expression of E2F4 mRNA",,,PMID:30665718,https://www.ncbi.nlm.nih.gov/pubmed/30665718,30665718,,
76,456645,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906,EDN1,10116,Rattus norvegicus (Norway rat),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [EDN1 protein results in increased expression of and results in increased cleavage of PARP1 protein]",,,PMID:24932781,https://www.ncbi.nlm.nih.gov/pubmed/24932781,24932781,,
77,456646,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,84455,EFCAB7,https://ctdbase.org/detail.go?type=gene&acc=84455,,,84455,EFCAB7,10090,Mus musculus (house mouse),"[hydrogen peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of EFCAB7 protein",,,PMID:31494107,https://www.ncbi.nlm.nih.gov/pubmed/31494107,31494107,,
78,456647,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,23301,EHBP1,https://ctdbase.org/detail.go?type=gene&acc=23301,,,23301,EHBP1,10090,Mus musculus (house mouse),"[hydrogen peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of EHBP1 protein",,,PMID:31494107,https://www.ncbi.nlm.nih.gov/pubmed/31494107,31494107,,
79,456648,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,254102,EHBP1L1,https://ctdbase.org/detail.go?type=gene&acc=254102,,,254102,EHBP1L1,10090,Mus musculus (house mouse),"[hydrogen peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of EHBP1L1 protein",,,PMID:31494107,https://www.ncbi.nlm.nih.gov/pubmed/31494107,31494107,,
80,456649,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,8662,EIF3B,https://ctdbase.org/detail.go?type=gene&acc=8662,,,8662,EIF3B,10090,Mus musculus (house mouse),"[hydrogen peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of EIF3B protein|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [hydrogen peroxide results in increased phosphorylation of EIF3B protein]",,,PMID:31494107,https://www.ncbi.nlm.nih.gov/pubmed/31494107,31494107,,
81,525429,5291,Drug Gene Interaction database (DGIdb),Imatinib,,IMATINIB,https://www.dgidb.org/drugs/rxcui:282388,,NF2,https://www.dgidb.org/genes/hgnc:7773,,,4771,NF2,9606,Homo sapiens (human),,,,,,,,
82,525430,5291,Drug Gene Interaction database (DGIdb),Imatinib,,IMATINIB,https://www.dgidb.org/drugs/rxcui:282388,,BCR,https://www.dgidb.org/genes/hgnc:1014,,,613,BCR,9606,Homo sapiens (human),Inhibitor,,,,,,,
83,525431,5291,Drug Gene Interaction database (DGIdb),Imatinib,,IMATINIB,https://www.dgidb.org/drugs/rxcui:282388,,CSF1R,https://www.dgidb.org/genes/hgnc:2433,,,1436,CSF1R,9606,Homo sapiens (human),,,,,,,,
84,525432,5291,Drug Gene Interaction database (DGIdb),Imatinib,,IMATINIB,https://www.dgidb.org/drugs/rxcui:282388,,KIT,https://www.dgidb.org/genes/hgnc:6342,,,3815,KIT,9606,Homo sapiens (human),Inhibitor,,,,,,,
85,525433,5291,Drug Gene Interaction database (DGIdb),Imatinib,,IMATINIB,https://www.dgidb.org/drugs/rxcui:282388,,KIT,https://www.dgidb.org/genes/hgnc:6342,,,3815,KIT,9606,Homo sapiens (human),,,,,,,,
86,525434,5291,Therapeutic Target Database (TTD),Imatinib,D0AZ3C,Imatinib,https://idrblab.net/ttd/data/drug/details/D0AZ3C,T57700,Tyrosine-protein kinase Kit (KIT),https://idrblab.net/ttd/data/target/details/T57700,P10721,Mast/stem cell growth factor receptor Kit,3815,KIT,9606,Homo sapiens (human),Inhibitor,,,,,,,
87,524920,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,644943,RASSF10,https://ctdbase.org/detail.go?type=gene&acc=644943,,,644943,RASSF10,9606,Homo sapiens (human),Vorinostat results in decreased expression of RASSF10 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
88,524921,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,11228,RASSF8,https://ctdbase.org/detail.go?type=gene&acc=11228,,,11228,RASSF8,9606,Homo sapiens (human),Vorinostat results in decreased expression of RASSF8 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
89,524922,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,30062,RAX,https://ctdbase.org/detail.go?type=gene&acc=30062,,,30062,RAX,9606,Homo sapiens (human),"[NOG protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAX mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
90,524923,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925,RB1,9606,Homo sapiens (human),[bortezomib co-treated with vorinostat] results in increased degradation of RB1 protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,
91,524924,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925,RB1,9606,Homo sapiens (human),Vorinostat results in decreased phosphorylation of and results in increased cleavage of RB1 protein,,,PMID:10597302,https://www.ncbi.nlm.nih.gov/pubmed/10597302,10597302,,
92,524925,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925,RB1,9606,Homo sapiens (human),Vorinostat results in decreased phosphorylation of RB1 protein,,,PMID:14707268,https://www.ncbi.nlm.nih.gov/pubmed/14707268,14707268,,
93,526893,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,22838,RNF44,https://ctdbase.org/detail.go?type=gene&acc=22838,,,22838,RNF44,9606,Homo sapiens (human),Vorinostat results in decreased expression of RNF44 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
94,526894,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6095,RORA,https://ctdbase.org/detail.go?type=gene&acc=6095,,,6095,RORA,9606,Homo sapiens (human),Vorinostat results in decreased expression of RORA mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
95,526895,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6097,RORC,https://ctdbase.org/detail.go?type=gene&acc=6097,,,6097,RORC,10029,Cricetulus griseus (Chinese hamster),Vorinostat results in increased activity of RORC protein,,,PMID:30818834,https://www.ncbi.nlm.nih.gov/pubmed/30818834,30818834,,
96,526896,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6119,RPA3,https://ctdbase.org/detail.go?type=gene&acc=6119,,,6119,RPA3,9606,Homo sapiens (human),Vorinostat results in increased expression of RPA3 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
97,526897,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6136,RPL12,https://ctdbase.org/detail.go?type=gene&acc=6136,,,6136,RPL12,9606,Homo sapiens (human),Vorinostat results in decreased expression of RPL12 protein,,,PMID:20543569,https://www.ncbi.nlm.nih.gov/pubmed/20543569,20543569,,
98,526898,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6167,RPL37,https://ctdbase.org/detail.go?type=gene&acc=6167,,,6167,RPL37,9606,Homo sapiens (human),Vorinostat results in decreased expression of RPL37 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
99,527395,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6259,RYK,https://ctdbase.org/detail.go?type=gene&acc=6259,,,6259,RYK,9606,Homo sapiens (human),Vorinostat results in increased expression of RYK mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
100,527396,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6261,RYR1,https://ctdbase.org/detail.go?type=gene&acc=6261,,,6261,RYR1,9606,Homo sapiens (human),Vorinostat results in decreased expression of RYR1 mRNA,,,PMID:18769122,https://www.ncbi.nlm.nih.gov/pubmed/18769122,18769122,,
101,527397,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6262,RYR2,https://ctdbase.org/detail.go?type=gene&acc=6262,,,6262,RYR2,9606,Homo sapiens (human),Vorinostat results in decreased expression of RYR2 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
102,527398,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6263,RYR3,https://ctdbase.org/detail.go?type=gene&acc=6263,,,6263,RYR3,9606,Homo sapiens (human),"[NOG protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RYR3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
103,526395,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,27341,RRP7A,https://ctdbase.org/detail.go?type=gene&acc=27341,,,27341,RRP7A,9606,Homo sapiens (human),Temozolomide results in decreased expression of RRP7A mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
104,526396,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,23378,RRP8,https://ctdbase.org/detail.go?type=gene&acc=23378,,,23378,RRP8,9606,Homo sapiens (human),Temozolomide results in increased expression of RRP8 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
105,526397,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,91543,RSAD2,https://ctdbase.org/detail.go?type=gene&acc=91543,,,91543,RSAD2,9606,Homo sapiens (human),Temozolomide results in increased expression of RSAD2 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
106,526398,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,6248,RSC1A1,https://ctdbase.org/detail.go?type=gene&acc=6248,,,6248,RSC1A1,9606,Homo sapiens (human),Temozolomide results in increased expression of RSC1A1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
107,526399,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,6251,RSU1,https://ctdbase.org/detail.go?type=gene&acc=6251,,,6251,RSU1,9606,Homo sapiens (human),Temozolomide results in decreased expression of RSU1 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
108,526575,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,201965,RWDD4,https://ctdbase.org/detail.go?type=gene&acc=201965,,,201965,RWDD4,9606,Homo sapiens (human),Temozolomide results in decreased expression of RWDD4 mRNA,,,PMID:31758290,https://www.ncbi.nlm.nih.gov/pubmed/31758290,31758290,,
109,525250,5413,Comparative Toxicogenomics Database (CTD),Tetraethylammonium,D019789,Tetraethylammonium,https://ctdbase.org/detail.go?type=chem&acc=D019789,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244,SLC47A1,9606,Homo sapiens (human),Pyrimethamine inhibits the reaction [SLC47A1 protein results in increased uptake of tetraethylammonium],,,PMID:32305507,https://www.ncbi.nlm.nih.gov/pubmed/32305507,32305507,,
110,525251,5413,Comparative Toxicogenomics Database (CTD),Tetraethylammonium,D019789,Tetraethylammonium,https://ctdbase.org/detail.go?type=chem&acc=D019789,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244,SLC47A1,9606,Homo sapiens (human),SLC47A1 protein affects the transport of tetraethylammonium,,,PMID:16928787,https://www.ncbi.nlm.nih.gov/pubmed/16928787,16928787,,
111,525252,5413,Comparative Toxicogenomics Database (CTD),Tetraethylammonium,D019789,Tetraethylammonium,https://ctdbase.org/detail.go?type=chem&acc=D019789,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244,SLC47A1,9606,Homo sapiens (human),SLC47A1 protein polymorphism results in decreased uptake of tetraethylammonium,,,PMID:19172157,https://www.ncbi.nlm.nih.gov/pubmed/19172157,19172157,,
112,525253,5413,Comparative Toxicogenomics Database (CTD),Tetraethylammonium,D019789,Tetraethylammonium,https://ctdbase.org/detail.go?type=chem&acc=D019789,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244,SLC47A1,9606,Homo sapiens (human),SLC47A1 protein results in increased import of tetraethylammonium|tobacco smoke pollution inhibits the reaction [SLC47A1 protein results in increased import of tetraethylammonium]|verapamil inhibits the reaction [SLC47A1 protein results in increased import of tetraethylammonium],,,PMID:27450509,https://www.ncbi.nlm.nih.gov/pubmed/27450509,27450509,,
113,525254,5413,Comparative Toxicogenomics Database (CTD),Tetraethylammonium,D019789,Tetraethylammonium,https://ctdbase.org/detail.go?type=chem&acc=D019789,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244,SLC47A1,9606,Homo sapiens (human),SLC47A1 protein results in increased uptake of tetraethylammonium,,,PMID:19172157|PMID:27989701|PMID:32305507,https://www.ncbi.nlm.nih.gov/pubmed/19172157|https://www.ncbi.nlm.nih.gov/pubmed/27989701|https://www.ncbi.nlm.nih.gov/pubmed/32305507,19172157|27989701|32305507,,
114,525255,5413,Comparative Toxicogenomics Database (CTD),Tetraethylammonium,D019789,Tetraethylammonium,https://ctdbase.org/detail.go?type=chem&acc=D019789,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244,SLC47A1,9606,Homo sapiens (human),Tetraethylammonium inhibits the reaction [SLC47A1 protein affects the uptake of paraquat],,,PMID:17495125,https://www.ncbi.nlm.nih.gov/pubmed/17495125,17495125,,
115,525426,5413,Comparative Toxicogenomics Database (CTD),Tetraethylammonium,D019789,Tetraethylammonium,https://ctdbase.org/detail.go?type=chem&acc=D019789,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582,SLC22A2,9606,Homo sapiens (human),Tetraethylammonium inhibits the reaction [SLC22A2 protein results in increased uptake of ethidium],,,PMID:19357179,https://www.ncbi.nlm.nih.gov/pubmed/19357179,19357179,,
116,525427,5413,Comparative Toxicogenomics Database (CTD),Tetraethylammonium,D019789,Tetraethylammonium,https://ctdbase.org/detail.go?type=chem&acc=D019789,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582,SLC22A2,9986,Oryctolagus cuniculus (rabbit),SLC22A2 protein results in increased uptake of tetraethylammonium|cadmium inhibits the reaction [SLC22A2 protein results in increased uptake of tetraethylammonium]|tetraethylammonium inhibits the reaction [SLC22A2 protein results in increased uptake of cadmium],,,PMID:21513783,https://www.ncbi.nlm.nih.gov/pubmed/21513783,21513783,,
117,525428,5413,Comparative Toxicogenomics Database (CTD),Tetraethylammonium,D019789,Tetraethylammonium,https://ctdbase.org/detail.go?type=chem&acc=D019789,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582,SLC22A2,10116,Rattus norvegicus (Norway rat),Disopyramide affects the reaction [SLC22A2 protein results in increased uptake of tetraethylammonium]|chlorpheniramine affects the reaction [SLC22A2 protein results in increased uptake of tetraethylammonium]|dopamine affects the reaction [SLC22A2 protein results in increased uptake of tetraethylammonium]|1-methyl-4-phenylpyridinium affects the reaction [SLC22A2 protein results in increased uptake of tetraethylammonium],,,PMID:12440152,https://www.ncbi.nlm.nih.gov/pubmed/12440152,12440152,,
118,524724,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,64271,EPHA4A,https://ctdbase.org/detail.go?type=gene&acc=64271,,,64271,epha4a,7955,Danio rerio (zebrafish),Thiram results in decreased expression of EPHA4A mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
119,524725,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,30313,EPHB3A,https://ctdbase.org/detail.go?type=gene&acc=30313,,,30313,ephb3a,7955,Danio rerio (zebrafish),Thiram results in decreased expression of EPHB3A mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
120,524726,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,30691,EPHB4B,https://ctdbase.org/detail.go?type=gene&acc=30691,,,30691,ephb4b,7955,Danio rerio (zebrafish),Thiram results in decreased expression of EPHB4B mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
121,524727,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053,EPHX2,7955,Danio rerio (zebrafish),Thiram results in decreased expression of EPHX2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
122,524728,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,29924,EPN1,https://ctdbase.org/detail.go?type=gene&acc=29924,,,29924,EPN1,7955,Danio rerio (zebrafish),Thiram results in decreased expression of EPN1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
123,524729,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,568170,EPS15L1A,https://ctdbase.org/detail.go?type=gene&acc=568170,,,568170,eps15l1a,7955,Danio rerio (zebrafish),Thiram results in decreased expression of EPS15L1A mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
124,524730,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,1161,ERCC8,https://ctdbase.org/detail.go?type=gene&acc=1161,,,1161,ERCC8,7955,Danio rerio (zebrafish),Thiram results in increased expression of ERCC8 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
125,524731,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,51290,ERGIC2,https://ctdbase.org/detail.go?type=gene&acc=51290,,,51290,ERGIC2,7955,Danio rerio (zebrafish),Thiram results in decreased expression of ERGIC2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
126,526074,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,84717,HDGFL2,https://ctdbase.org/detail.go?type=gene&acc=84717,,,84717,HDGFL2,7955,Danio rerio (zebrafish),Thiram results in decreased expression of HDGFL2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
127,526075,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,23593,HEBP2,https://ctdbase.org/detail.go?type=gene&acc=23593,,,23593,HEBP2,7955,Danio rerio (zebrafish),Thiram results in increased expression of HEBP2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
128,527399,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,3621,ING1,https://ctdbase.org/detail.go?type=gene&acc=3621,,,3621,ING1,7955,Danio rerio (zebrafish),Thiram results in increased expression of ING1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
129,527400,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,51141,INSIG2,https://ctdbase.org/detail.go?type=gene&acc=51141,,,51141,INSIG2,7955,Danio rerio (zebrafish),Thiram results in decreased expression of INSIG2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
130,527401,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,25896,INTS7,https://ctdbase.org/detail.go?type=gene&acc=25896,,,25896,INTS7,7955,Danio rerio (zebrafish),Thiram results in decreased expression of INTS7 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
131,527402,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,3659,IRF1,https://ctdbase.org/detail.go?type=gene&acc=3659,,,3659,IRF1,7955,Danio rerio (zebrafish),Thiram results in increased expression of IRF1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
132,527403,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,405815,IRF10,https://ctdbase.org/detail.go?type=gene&acc=405815,,,405815,irf10,7955,Danio rerio (zebrafish),Thiram results in increased expression of IRF10 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
133,527404,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,406614,IRF2BP2B,https://ctdbase.org/detail.go?type=gene&acc=406614,,,406614,irf2bp2b,7955,Danio rerio (zebrafish),Thiram results in decreased expression of IRF2BP2B mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
134,527405,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,3678,ITGA5,https://ctdbase.org/detail.go?type=gene&acc=3678,,,3678,ITGA5,7955,Danio rerio (zebrafish),Thiram results in decreased expression of ITGA5 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
135,528039,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949,LDLR,7955,Danio rerio (zebrafish),Thiram results in decreased expression of LDLR mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
136,528040,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176,LEF1,7955,Danio rerio (zebrafish),Thiram results in increased expression of LEF1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
137,528041,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952,LEP,10116,Rattus norvegicus (Norway rat),"[2-amino-3-chloro-1,4-naphthoquinone co-treated with ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with thiram] results in increased expression of LEP protein",,,PMID:29321614,https://www.ncbi.nlm.nih.gov/pubmed/29321614,29321614,,
138,528042,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953,LEPR,10116,Rattus norvegicus (Norway rat),"[2-amino-3-chloro-1,4-naphthoquinone co-treated with ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with thiram] results in decreased expression of LEPR mRNA",,,PMID:29321614,https://www.ncbi.nlm.nih.gov/pubmed/29321614,29321614,,
139,528043,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972,LHB,7955,Danio rerio (zebrafish),Thiram results in increased expression of LHB mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
140,526076,5526,ChEMBL,Tranexamic acid,CHEMBL877,TRANEXAMIC ACID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL877/,CHEMBL1801,Plasminogen,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1801/,P00747,Plasminogen,5340,PLG,9606,Homo sapiens (human),Plasminogen inhibitor,,,,,,,
141,526077,5533,Drug Gene Interaction database (DGIdb),Trazodone,,TRAZODONE,https://www.dgidb.org/drugs/rxcui:10737,,HTR2C,https://www.dgidb.org/genes/hgnc:5295,,,3358,HTR2C,9606,Homo sapiens (human),Inhibitor,,,,,,,
142,526078,5533,Drug Gene Interaction database (DGIdb),Trazodone,,TRAZODONE,https://www.dgidb.org/drugs/rxcui:10737,,HTR1A,https://www.dgidb.org/genes/hgnc:5286,,,3350,HTR1A,9606,Homo sapiens (human),,,,,,,,
143,526079,5541,Comparative Toxicogenomics Database (CTD),Triacetin,D014215,Triacetin,https://ctdbase.org/detail.go?type=chem&acc=D014215,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),[biofuels co-treated with triacetin] results in decreased expression of CASP3 mRNA,,,PMID:30738890,https://www.ncbi.nlm.nih.gov/pubmed/30738890,30738890,,
144,526080,5541,Comparative Toxicogenomics Database (CTD),Triacetin,D014215,Triacetin,https://ctdbase.org/detail.go?type=chem&acc=D014215,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),[biofuels co-treated with triacetin] results in increased secretion of CXCL8 protein,,,PMID:30738890,https://www.ncbi.nlm.nih.gov/pubmed/30738890,30738890,,
145,526081,5541,Comparative Toxicogenomics Database (CTD),Triacetin,D014215,Triacetin,https://ctdbase.org/detail.go?type=chem&acc=D014215,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),[biofuels co-treated with triacetin] results in decreased expression of BCL2 mRNA,,,PMID:30738890,https://www.ncbi.nlm.nih.gov/pubmed/30738890,30738890,,
146,526082,5541,Comparative Toxicogenomics Database (CTD),Triacetin,D014215,Triacetin,https://ctdbase.org/detail.go?type=chem&acc=D014215,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543,CYP1A1,9606,Homo sapiens (human),[biofuels co-treated with triacetin] affects the expression of CYP1A1 mRNA,,,PMID:30738890,https://www.ncbi.nlm.nih.gov/pubmed/30738890,30738890,,
147,526083,5541,Comparative Toxicogenomics Database (CTD),Triacetin,D014215,Triacetin,https://ctdbase.org/detail.go?type=chem&acc=D014215,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,9606,Homo sapiens (human),Triacetin results in increased expression of DDIT3 mRNA,,,PMID:21703327,https://www.ncbi.nlm.nih.gov/pubmed/21703327,21703327,,
148,570553,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,51032,CELA2B,https://ctdbase.org/detail.go?type=gene&acc=51032,,,51032,CELA2B,9606,Homo sapiens (human),Triclosan results in increased expression of CELA2B mRNA,,,PMID:30510588,https://www.ncbi.nlm.nih.gov/pubmed/30510588,30510588,,
149,570554,5564,Comparative Toxicogenomics Database (CTD),Triclosan,D014260,Triclosan,https://ctdbase.org/detail.go?type=chem&acc=D014260,23436,CELA3B,https://ctdbase.org/detail.go?type=gene&acc=23436,,,23436,CELA3B,9031,Gallus gallus (chicken),Triclosan results in increased expression of CELA3B mRNA,,,PMID:29596926,https://www.ncbi.nlm.nih.gov/pubmed/29596926,29596926,,
150,524916,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632,BGLAP,10116,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of BGLAP mRNA,,,PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16813520,16813520,,
151,524917,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,633,BGN,https://ctdbase.org/detail.go?type=gene&acc=633,,,633,BGN,10090,Mus musculus (house mouse),Troglitazone results in increased expression of BGN mrna|troglitazone results in decreased expression of BGN mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
152,524918,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,70237,BHLHB9,https://ctdbase.org/detail.go?type=gene&acc=70237,,,70237,Bhlhb9,10090,Mus musculus (house mouse),Troglitazone results in increased expression of BHLHB9 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
153,524919,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,8553,BHLHE40,https://ctdbase.org/detail.go?type=gene&acc=8553,,,8553,BHLHE40,9606,Homo sapiens (human),Troglitazone results in decreased expression of BHLHE40 mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
154,526245,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,718,C3,https://ctdbase.org/detail.go?type=gene&acc=718,,,718,C3,9606,Homo sapiens (human),Troglitazone results in decreased expression of C3 mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
155,526246,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,725,C4BPB,https://ctdbase.org/detail.go?type=gene&acc=725,,,725,C4BPB,10116,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of C4BPB mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
156,526247,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,27202,C5AR2,https://ctdbase.org/detail.go?type=gene&acc=27202,,,27202,C5AR2,10116,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of C5AR2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
157,526248,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,96989,C79685,https://ctdbase.org/detail.go?type=gene&acc=96989,,,96989,C79685,10090,Mus musculus (house mouse),Troglitazone results in increased expression of C79685 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
158,526249,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,731,C8A,https://ctdbase.org/detail.go?type=gene&acc=731,,,731,C8A,9606,Homo sapiens (human),Troglitazone results in decreased expression of C8A mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
159,526250,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,732,C8B,https://ctdbase.org/detail.go?type=gene&acc=732,,,732,C8B,9606,Homo sapiens (human),Troglitazone results in decreased expression of C8B mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
160,526251,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,733,C8G,https://ctdbase.org/detail.go?type=gene&acc=733,,,733,C8G,9606,Homo sapiens (human),Troglitazone results in decreased expression of C8G mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
161,526252,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,771,CA12,https://ctdbase.org/detail.go?type=gene&acc=771,,,771,CA12,9606,Homo sapiens (human),Troglitazone results in increased expression of CA12 mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
162,526253,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,767,CA8,https://ctdbase.org/detail.go?type=gene&acc=767,,,767,CA8,10090,Mus musculus (house mouse),Troglitazone results in decreased expression of CA8 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
163,526889,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841,CASP8,9606,Homo sapiens (human),Troglitazone results in increased expression of CASP8,,,PMID:12680223,https://www.ncbi.nlm.nih.gov/pubmed/12680223,12680223,,
164,526890,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841,CASP8,9606,Homo sapiens (human),Troglitazone results in increased expression of CASP8 protein modified form,,,PMID:16820965,https://www.ncbi.nlm.nih.gov/pubmed/16820965,16820965,,
165,526891,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841,CASP8,10090,Mus musculus (house mouse),Troglitazone results in increased expression of CASP8 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
166,526892,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,9606,Homo sapiens (human),"Troglitazone results in increased expression of CASP9 protein|[n-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP9 protein]|gsk3b protein affects the susceptibility to [troglitazone results in increased expression of CASP9 protein]",,,PMID:20540935,https://www.ncbi.nlm.nih.gov/pubmed/20540935,20540935,,
167,528182,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,54575,UGT1A10,https://ctdbase.org/detail.go?type=gene&acc=54575,,,54575,UGT1A10,9606,Homo sapiens (human),Troglitazone results in increased expression of UGT1A10 mRNA,,,PMID:19022234,https://www.ncbi.nlm.nih.gov/pubmed/19022234,19022234,,
168,528325,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,54657,UGT1A4,https://ctdbase.org/detail.go?type=gene&acc=54657,,,54657,UGT1A4,9606,Homo sapiens (human),Troglitazone results in decreased expression of UGT1A4 mrna|troglitazone results in increased expression of UGT1A4 mRNA,,,PMID:19631733,https://www.ncbi.nlm.nih.gov/pubmed/19631733,19631733,,
169,528326,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,24862,UGT2B,https://ctdbase.org/detail.go?type=gene&acc=24862,,,24862,Ugt2b,10116,Rattus norvegicus (Norway rat),UGT2B protein results in increased glucuronidation of troglitazone,,,PMID:11201174,https://www.ncbi.nlm.nih.gov/pubmed/11201174,11201174,,
170,528327,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,29128,UHRF1,https://ctdbase.org/detail.go?type=gene&acc=29128,,,29128,UHRF1,9606,Homo sapiens (human),Troglitazone results in decreased expression of UHRF1 mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
171,534452,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,22849,CPEB3,https://ctdbase.org/detail.go?type=gene&acc=22849,,,22849,CPEB3,10090,Mus musculus (house mouse),Troglitazone results in decreased expression of CPEB3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
172,524732,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,15024,H2-T10,https://ctdbase.org/detail.go?type=gene&acc=15024,,,15024,H2-T10,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of H2-T10 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
173,524733,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,15039,H2-T22,https://ctdbase.org/detail.go?type=gene&acc=15039,,,15039,H2-T22,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of H2-T22 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
174,525246,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,51495,HACD3,https://ctdbase.org/detail.go?type=gene&acc=51495,,,51495,HACD3,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of HACD3 mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
175,525247,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,401494,HACD4,https://ctdbase.org/detail.go?type=gene&acc=401494,,,401494,HACD4,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of HACD4 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
176,525248,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,26061,HACL1,https://ctdbase.org/detail.go?type=gene&acc=26061,,,26061,HACL1,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HACL1 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
177,525249,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,26061,HACL1,https://ctdbase.org/detail.go?type=gene&acc=26061,,,26061,HACL1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of HACL1 mRNA,,,PMID:17426115|PMID:18301758|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/17426115|https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/23811191,17426115|18301758|23811191,,
178,525744,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,16625,SERPINA3C,https://ctdbase.org/detail.go?type=gene&acc=16625,,,16625,Serpina3c,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPINA3C mRNA,,,PMID:16221962|PMID:20059764|PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/16221962|https://www.ncbi.nlm.nih.gov/pubmed/20059764|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,16221962|20059764|20813756|23811191,,
179,525745,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,16625,SERPINA3C,https://ctdbase.org/detail.go?type=gene&acc=16625,,,16625,Serpina3c,10090,Mus musculus (house mouse),PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SERPINA3C mrna],,,PMID:20059764,https://www.ncbi.nlm.nih.gov/pubmed/20059764,20059764,,
180,525746,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,238395,SERPINA3J,https://ctdbase.org/detail.go?type=gene&acc=238395,,,238395,Serpina3j,10090,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in decreased expression of SERPINA3J mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
181,525747,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,238395,SERPINA3J,https://ctdbase.org/detail.go?type=gene&acc=238395,,,238395,Serpina3j,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPINA3J mRNA,,,PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,20813756|23811191,,
182,525748,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20714,SERPINA3K,https://ctdbase.org/detail.go?type=gene&acc=20714,,,20714,Serpina3k,10090,Mus musculus (house mouse),Pirinixic acid affects the expression of SERPINA3K mRNA,,,PMID:19136022,https://www.ncbi.nlm.nih.gov/pubmed/19136022,19136022,,
183,525749,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20714,SERPINA3K,https://ctdbase.org/detail.go?type=gene&acc=20714,,,20714,Serpina3k,10090,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in decreased expression of SERPINA3K mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
184,525750,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20714,SERPINA3K,https://ctdbase.org/detail.go?type=gene&acc=20714,,,20714,Serpina3k,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SERPINA3K mRNA,,,PMID:11798191|PMID:19850644|PMID:20059764|PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/11798191|https://www.ncbi.nlm.nih.gov/pubmed/19850644|https://www.ncbi.nlm.nih.gov/pubmed/20059764|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,11798191|19850644|20059764|20813756|23811191,,
185,525751,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20714,SERPINA3K,https://ctdbase.org/detail.go?type=gene&acc=20714,,,20714,Serpina3k,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of SERPINA3K mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
186,525752,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,20714,SERPINA3K,https://ctdbase.org/detail.go?type=gene&acc=20714,,,20714,Serpina3k,10090,Mus musculus (house mouse),PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SERPINA3K mrna],,,PMID:19850644|PMID:20059764,https://www.ncbi.nlm.nih.gov/pubmed/19850644|https://www.ncbi.nlm.nih.gov/pubmed/20059764,19850644|20059764,,
187,526243,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,89777,SERPINB12,https://ctdbase.org/detail.go?type=gene&acc=89777,,,89777,SERPINB12,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of SERPINB12 mrna|[pirinixic acid co-treated with PPARA] results in increased expression of SERPINB12 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
188,526244,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,66222,SERPINB1A,https://ctdbase.org/detail.go?type=gene&acc=66222,,,66222,Serpinb1a,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of SERPINB1A mRNA,,,PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,20813756|23811191,,
189,526723,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3052,HCCS,https://ctdbase.org/detail.go?type=gene&acc=3052,,,3052,HCCS,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of HCCS mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
190,526724,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,54985,HCFC1R1,https://ctdbase.org/detail.go?type=gene&acc=54985,,,54985,HCFC1R1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of HCFC1R1 mRNA,,,PMID:18301758|PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/20813756,18301758|20813756,,
191,526725,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,29915,HCFC2,https://ctdbase.org/detail.go?type=gene&acc=29915,,,29915,HCFC2,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HCFC2 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
192,526726,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3055,HCK,https://ctdbase.org/detail.go?type=gene&acc=3055,,,3055,HCK,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of HCK mRNA,,,PMID:17426115,https://www.ncbi.nlm.nih.gov/pubmed/17426115,17426115,,
193,526727,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,57657,HCN3,https://ctdbase.org/detail.go?type=gene&acc=57657,,,57657,HCN3,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of HCN3 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
194,526728,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3060,HCRT,https://ctdbase.org/detail.go?type=gene&acc=3060,,,3060,HCRT,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of HCRT mrna|[pirinixic acid co-treated with PPARA] results in decreased expression of HCRT mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
195,526729,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,3061,HCRTR1,https://ctdbase.org/detail.go?type=gene&acc=3061,,,3061,HCRTR1,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HCRTR1 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
196,526730,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,10870,HCST,https://ctdbase.org/detail.go?type=gene&acc=10870,,,10870,HCST,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of HCST mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
197,526731,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,79885,HDAC11,https://ctdbase.org/detail.go?type=gene&acc=79885,,,79885,HDAC11,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HDAC11 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
198,527076,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,23067,SETD1B,https://ctdbase.org/detail.go?type=gene&acc=23067,,,23067,SETD1B,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of SETD1B mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
199,527077,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,54093,SETD4,https://ctdbase.org/detail.go?type=gene&acc=54093,,,54093,SETD4,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of SETD4 mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
200,527078,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,55209,SETD5,https://ctdbase.org/detail.go?type=gene&acc=55209,,,55209,SETD5,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of SETD5 mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
201,555204,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,51196,PLCE1,https://ctdbase.org/detail.go?type=gene&acc=51196,,,51196,PLCE1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of PLCE1 mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
202,555205,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,5336,PLCG2,https://ctdbase.org/detail.go?type=gene&acc=5336,,,5336,PLCG2,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLCG2 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
203,555206,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,5336,PLCG2,https://ctdbase.org/detail.go?type=gene&acc=5336,,,5336,PLCG2,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of PLCG2 mRNA,,,PMID:17426115,https://www.ncbi.nlm.nih.gov/pubmed/17426115,17426115,,
204,555207,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,5336,PLCG2,https://ctdbase.org/detail.go?type=gene&acc=5336,,,5336,PLCG2,10116,Rattus norvegicus (Norway rat),Pirinixic acid results in increased expression of PLCG2 mRNA,,,PMID:16940010,https://www.ncbi.nlm.nih.gov/pubmed/16940010,16940010,,
205,527248,5708,Comparative Toxicogenomics Database (CTD),"1,4-Phenylenebis(methylene)selenocyanate",C074153,"1,4-phenylenebis(methylene)selenocyanate",https://ctdbase.org/detail.go?type=chem&acc=C074153,2880,GPX5,https://ctdbase.org/detail.go?type=gene&acc=2880,,,2880,GPX5,9606,Homo sapiens (human),"1,4-phenylenebis(methylene)selenocyanate results in increased expression of GPX5 mRNA",,,PMID:16399772,https://www.ncbi.nlm.nih.gov/pubmed/16399772,16399772,,
206,493068,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,1655,DDX5,https://ctdbase.org/detail.go?type=gene&acc=1655,,,1655,DDX5,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of DDX5 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of DDX5 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
207,555024,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544,PROCR,9606,Homo sapiens (human),Dexamethasone results in increased expression of PROCR mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
208,555025,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544,PROCR,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of PROCR mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of PROCR mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
209,555026,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,51450,PRRX2,https://ctdbase.org/detail.go?type=gene&acc=51450,,,51450,PRRX2,9606,Homo sapiens (human),Dexamethasone results in decreased expression of PRRX2 mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
210,555027,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544,PROCR,9940,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PROCR mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
211,555028,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842,PROM1,9940,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PROM1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
212,555029,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,564431,PROX3,https://ctdbase.org/detail.go?type=gene&acc=564431,,,564431,prox3,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of PROX3 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
213,524577,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2707,GJB3,https://ctdbase.org/detail.go?type=gene&acc=2707,,,2707,GJB3,9606,Homo sapiens (human),[estradiol binds to ESR2 protein] which results in increased expression of GJB3 mRNA,,,PMID:20404318,https://www.ncbi.nlm.nih.gov/pubmed/20404318,20404318,,
214,524578,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,127534,GJB4,https://ctdbase.org/detail.go?type=gene&acc=127534,,,127534,GJB4,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of GJB4 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
215,524579,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2709,GJB5,https://ctdbase.org/detail.go?type=gene&acc=2709,,,2709,GJB5,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of GJB5 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
216,524580,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,402821,GJB9B,https://ctdbase.org/detail.go?type=gene&acc=402821,,,402821,gjb9b,8090,Oryzias latipes (Japanese medaka),Estradiol results in increased expression of GJB9B mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
217,524581,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10052,GJC1,https://ctdbase.org/detail.go?type=gene&acc=10052,,,10052,GJC1,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of GJC1 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
218,524582,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,349149,GJC3,https://ctdbase.org/detail.go?type=gene&acc=349149,,,349149,GJC3,10116,Rattus norvegicus (Norway rat),Estradiol affects the expression of GJC3 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
219,524583,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,125111,GJD3,https://ctdbase.org/detail.go?type=gene&acc=125111,,,125111,GJD3,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of GJD3 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
220,524584,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2710,GK,https://ctdbase.org/detail.go?type=gene&acc=2710,,,2710,GK,9606,Homo sapiens (human),Estradiol affects the expression of GK mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
221,525573,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2745,GLRX,https://ctdbase.org/detail.go?type=gene&acc=2745,,,2745,GLRX,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of GLRX mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
222,527681,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9950,GOLGA5,https://ctdbase.org/detail.go?type=gene&acc=9950,,,9950,GOLGA5,9606,Homo sapiens (human),Estradiol results in increased expression of GOLGA5 mRNA,,,PMID:16514628,https://www.ncbi.nlm.nih.gov/pubmed/16514628,16514628,,
223,527682,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,23015,GOLGA8A,https://ctdbase.org/detail.go?type=gene&acc=23015,,,23015,GOLGA8A,9606,Homo sapiens (human),Estradiol results in increased expression of GOLGA8A mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
224,527683,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2804,GOLGB1,https://ctdbase.org/detail.go?type=gene&acc=2804,,,2804,GOLGB1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of GOLGB1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
225,527684,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,27333,GOLIM4,https://ctdbase.org/detail.go?type=gene&acc=27333,,,27333,GOLIM4,9606,Homo sapiens (human),Estradiol results in decreased expression of GOLIM4 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
226,527685,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,27333,GOLIM4,https://ctdbase.org/detail.go?type=gene&acc=27333,,,27333,GOLIM4,9606,Homo sapiens (human),Estradiol results in increased expression of GOLIM4 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
227,527686,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,27333,GOLIM4,https://ctdbase.org/detail.go?type=gene&acc=27333,,,27333,GOLIM4,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of GOLIM4 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
228,527687,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51280,GOLM1,https://ctdbase.org/detail.go?type=gene&acc=51280,,,51280,GOLM1,9606,Homo sapiens (human),[estradiol co-treated with tetrachlorodibenzodioxin] results in increased expression of GOLM1 mRNA,,,PMID:19619570,https://www.ncbi.nlm.nih.gov/pubmed/19619570,19619570,,
229,527688,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51280,GOLM1,https://ctdbase.org/detail.go?type=gene&acc=51280,,,51280,GOLM1,9606,Homo sapiens (human),Estradiol results in increased expression of GOLM1 mRNA,,,PMID:19619570|PMID:21185374,https://www.ncbi.nlm.nih.gov/pubmed/19619570|https://www.ncbi.nlm.nih.gov/pubmed/21185374,19619570|21185374,,
230,527689,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51280,GOLM1,https://ctdbase.org/detail.go?type=gene&acc=51280,,,51280,GOLM1,10090,Mus musculus (house mouse),Estradiol results in increased expression of GOLM1 mRNA,,,PMID:15289156,https://www.ncbi.nlm.nih.gov/pubmed/15289156,15289156,,
231,527690,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,55204,GOLPH3L,https://ctdbase.org/detail.go?type=gene&acc=55204,,,55204,GOLPH3L,9606,Homo sapiens (human),Estradiol results in decreased expression of GOLPH3L mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
232,527865,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,127845,GOLT1A,https://ctdbase.org/detail.go?type=gene&acc=127845,,,127845,GOLT1A,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of GOLT1A mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
233,527866,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57120,GOPC,https://ctdbase.org/detail.go?type=gene&acc=57120,,,57120,GOPC,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of GOPC mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
234,527867,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9527,GOSR1,https://ctdbase.org/detail.go?type=gene&acc=9527,,,9527,GOSR1,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of GOSR1 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
235,526400,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,217698,ACOT5,https://ctdbase.org/detail.go?type=gene&acc=217698,,,217698,Acot5,10116,Rattus norvegicus (Norway rat),Cephaloridine results in decreased expression of ACOT5 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
236,526401,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,23597,ACOT9,https://ctdbase.org/detail.go?type=gene&acc=23597,,,23597,ACOT9,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of ACOT9 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
237,526402,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,54988,ACSM5,https://ctdbase.org/detail.go?type=gene&acc=54988,,,54988,ACSM5,10116,Rattus norvegicus (Norway rat),Cephaloridine results in decreased expression of ACSM5 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
238,526403,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,101,ADAM8,https://ctdbase.org/detail.go?type=gene&acc=101,,,101,ADAM8,10116,Rattus norvegicus (Norway rat),Cephaloridine results in decreased expression of ADAM8 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
239,526404,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,2015,ADGRE1,https://ctdbase.org/detail.go?type=gene&acc=2015,,,2015,ADGRE1,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of ADGRE1 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
240,526576,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,6718,AKR1D1,https://ctdbase.org/detail.go?type=gene&acc=6718,,,6718,AKR1D1,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of AKR1D1 mRNA,,,PMID:18172885,https://www.ncbi.nlm.nih.gov/pubmed/18172885,18172885,,
241,526577,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211,ALAS1,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of ALAS1 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
242,526578,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,218,ALDH3A1,https://ctdbase.org/detail.go?type=gene&acc=218,,,218,ALDH3A1,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of ALDH3A1 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
243,526579,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,221,ALDH3B1,https://ctdbase.org/detail.go?type=gene&acc=221,,,221,ALDH3B1,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of ALDH3B1 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
244,526580,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,226,ALDOA,https://ctdbase.org/detail.go?type=gene&acc=226,,,226,ALDOA,10116,Rattus norvegicus (Norway rat),Cephaloridine affects the expression of ALDOA mRNA,,,PMID:18172885,https://www.ncbi.nlm.nih.gov/pubmed/18172885,18172885,,
245,526581,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,219287,AMER2,https://ctdbase.org/detail.go?type=gene&acc=219287,,,219287,AMER2,10116,Rattus norvegicus (Norway rat),Cephaloridine results in decreased expression of AMER2 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
246,526582,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,347902,AMIGO2,https://ctdbase.org/detail.go?type=gene&acc=347902,,,347902,AMIGO2,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of AMIGO2 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
247,526583,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,270,AMPD1,https://ctdbase.org/detail.go?type=gene&acc=270,,,270,AMPD1,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of AMPD1 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
248,526584,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,272,AMPD3,https://ctdbase.org/detail.go?type=gene&acc=272,,,272,AMPD3,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of AMPD3 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
249,526585,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129,ANGPTL4,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of ANGPTL4 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
250,527536,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,6364,CCL20,https://ctdbase.org/detail.go?type=gene&acc=6364,,,6364,CCL20,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of CCL20 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
251,527537,5773,Comparative Toxicogenomics Database (CTD),Cephaloridine,D002509,Cephaloridine,https://ctdbase.org/detail.go?type=chem&acc=D002509,56477,CCL28,https://ctdbase.org/detail.go?type=gene&acc=56477,,,56477,CCL28,10116,Rattus norvegicus (Norway rat),Cephaloridine results in increased expression of CCL28 mRNA,,,PMID:18500788,https://www.ncbi.nlm.nih.gov/pubmed/18500788,18500788,,
252,425824,5826,DrugBank,Dextroamphetamine,DB01576,Dextroamphetamine,https://www.drugbank.ca/drugs/DB01576,BE0000118,Synaptic vesicular amine transporter,https://www.drugbank.ca/bio_entities/BE0000118,Q05940,Synaptic vesicular amine transporter,6571,SLC18A2,9606,Homo sapiens (human),Inducer,,,PMID:7751968|PMID:15955613,https://www.ncbi.nlm.nih.gov/pubmed/7751968|https://www.ncbi.nlm.nih.gov/pubmed/15955613,7751968|15955613,,
253,555023,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,54984,PINX1,https://ctdbase.org/detail.go?type=gene&acc=54984,,,54984,PINX1,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of PINX1 mrna|schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of PINX1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
254,563909,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,1131,CHRM3,https://ctdbase.org/detail.go?type=gene&acc=1131,,,1131,CHRM3,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of CHRM3 mRNA,,,PMID:16644059,https://www.ncbi.nlm.nih.gov/pubmed/16644059,16644059,,
255,525084,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,10090,Mus musculus (house mouse),Cycloheximide results in decreased expression of HMOX1 protein,,,PMID:24255720,https://www.ncbi.nlm.nih.gov/pubmed/24255720,24255720,,
256,525085,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,10116,Rattus norvegicus (Norway rat),Cycloheximide inhibits the reaction [cobaltous chloride results in increased expression of HMOX1 mrna],,,PMID:17002867,https://www.ncbi.nlm.nih.gov/pubmed/17002867,17002867,,
257,525929,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10116,Rattus norvegicus (Norway rat),Cycloheximide promotes the reaction [IL1B protein results in increased expression of PTGS2 mrna],,,PMID:11286988,https://www.ncbi.nlm.nih.gov/pubmed/11286988,11286988,,
258,525930,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3567,IL5,https://ctdbase.org/detail.go?type=gene&acc=3567,,,3567,IL5,10090,Mus musculus (house mouse),T0901317 inhibits the reaction [cycloheximide results in decreased expression of IL5 protein]|cycloheximide results in decreased expression of IL5 protein,,,PMID:23150660,https://www.ncbi.nlm.nih.gov/pubmed/23150660,23150660,,
259,525931,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),Cycloheximide inhibits the reaction [CXCL8 protein affects the secretion of IL6 protein],,,PMID:8071060,https://www.ncbi.nlm.nih.gov/pubmed/8071060,8071060,,
260,525932,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),Cycloheximide results in decreased secretion of IL6 protein,,,PMID:11216681,https://www.ncbi.nlm.nih.gov/pubmed/11216681,11216681,,
261,525933,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),Cycloheximide results in increased expression of IL6 mRNA,,,PMID:21146893|PMID:24771768,https://www.ncbi.nlm.nih.gov/pubmed/21146893|https://www.ncbi.nlm.nih.gov/pubmed/24771768,21146893|24771768,,
262,525934,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),Ursodeoxycholic acid analog inhibits the reaction [TNF protein promotes the reaction [cycloheximide results in increased secretion of IL6 protein]]|tnf protein promotes the reaction [cycloheximide results in increased secretion of IL6 protein]|cycloheximide results in increased secretion of IL6 protein|tnf protein promotes the reaction [cycloheximide results in increased expression of IL6 mrna]|ursodeoxycholic acid analog inhibits the reaction [TNF protein promotes the reaction [cycloheximide results in increased expression of IL6 mrna]],,,PMID:21146893,https://www.ncbi.nlm.nih.gov/pubmed/21146893,21146893,,
263,527068,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,9913,Bos taurus (cattle),Cycloheximide promotes the reaction [ALB protein results in increased phosphorylation of MAPK3 protein],,,PMID:23994741,https://www.ncbi.nlm.nih.gov/pubmed/23994741,23994741,,
264,527069,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,9606,Homo sapiens (human),Pertussis toxin inhibits the reaction [TAS2R105 protein affects the reaction [cycloheximide results in increased phosphorylation of MAPK3 protein]]|tas2r105 protein affects the reaction [cycloheximide results in increased phosphorylation of MAPK3 protein]|cycloheximide results in increased phosphorylation of MAPK3 protein,,,PMID:15087236,https://www.ncbi.nlm.nih.gov/pubmed/15087236,15087236,,
265,527070,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,10090,Mus musculus (house mouse),Cycloheximide inhibits the reaction [cyclosporine results in increased phosphorylation of MAPK3 protein],,,PMID:22155090,https://www.ncbi.nlm.nih.gov/pubmed/22155090,22155090,,
266,527071,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,10116,Rattus norvegicus (Norway rat),Cycloheximide inhibits the reaction [KNG1 protein results in increased phosphorylation of MAPK3 protein],,,PMID:16696851,https://www.ncbi.nlm.nih.gov/pubmed/16696851,16696851,,
267,527072,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,10116,Rattus norvegicus (Norway rat),Cycloheximide promotes the reaction [sodium arsenite promotes the reaction [hydrogen peroxide results in increased phosphorylation of MAPK3 protein]],,,PMID:12472888,https://www.ncbi.nlm.nih.gov/pubmed/12472888,12472888,,
268,527073,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,5598,MAPK7,https://ctdbase.org/detail.go?type=gene&acc=5598,,,5598,MAPK7,9606,Homo sapiens (human),Cycloheximide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of MAPK7 mrna],,,PMID:11007951,https://www.ncbi.nlm.nih.gov/pubmed/11007951,11007951,,
269,527074,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,5598,MAPK7,https://ctdbase.org/detail.go?type=gene&acc=5598,,,5598,MAPK7,9606,Homo sapiens (human),Cycloheximide results in increased expression of MAPK7 mrna|[tetrachlorodibenzodioxin co-treated with cycloheximide] results in increased expression of MAPK7 mRNA,,,PMID:19684285,https://www.ncbi.nlm.nih.gov/pubmed/19684285,19684285,,
270,527075,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,7867,MAPKAPK3,https://ctdbase.org/detail.go?type=gene&acc=7867,,,7867,MAPKAPK3,9606,Homo sapiens (human),MAPKAPK3 gene SNP affects the susceptibility to cycloheximide,,,PMID:25622337,https://www.ncbi.nlm.nih.gov/pubmed/25622337,25622337,,
271,528183,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609,MYC,10116,Rattus norvegicus (Norway rat),Cycloheximide promotes the reaction [cadmium results in increased expression of MYC mrna],,,PMID:1696944,https://www.ncbi.nlm.nih.gov/pubmed/1696944,1696944,,
272,528184,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,4638,MYLK,https://ctdbase.org/detail.go?type=gene&acc=4638,,,4638,MYLK,9606,Homo sapiens (human),Cycloheximide inhibits the reaction [TNF protein results in increased expression of MYLK protein],,,PMID:15701621,https://www.ncbi.nlm.nih.gov/pubmed/15701621,15701621,,
273,528185,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,4642,MYO1D,https://ctdbase.org/detail.go?type=gene&acc=4642,,,4642,MYO1D,9606,Homo sapiens (human),MYO1D gene SNP affects the susceptibility to cycloheximide,,,PMID:25622337,https://www.ncbi.nlm.nih.gov/pubmed/25622337,25622337,,
274,528186,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,4077,NBR1,https://ctdbase.org/detail.go?type=gene&acc=4077,,,4077,NBR1,9606,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with cycloheximide] results in increased expression of NBR1 mrna|cycloheximide results in increased expression of NBR1 mRNA,,,PMID:19684285,https://www.ncbi.nlm.nih.gov/pubmed/19684285,19684285,,
275,528187,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,10397,NDRG1,https://ctdbase.org/detail.go?type=gene&acc=10397,,,10397,NDRG1,9606,Homo sapiens (human),Cycloheximide results in decreased expression of NDRG1 protein|chloroquine inhibits the reaction [cycloheximide results in decreased expression of NDRG1 protein],,,PMID:28906492,https://www.ncbi.nlm.nih.gov/pubmed/28906492,28906492,,
276,528188,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,4734,NEDD4,https://ctdbase.org/detail.go?type=gene&acc=4734,,,4734,NEDD4,10090,Mus musculus (house mouse),Cycloheximide results in decreased expression of NEDD4 protein|melatonin promotes the reaction [cycloheximide results in decreased expression of NEDD4 protein],,,PMID:31325559,https://www.ncbi.nlm.nih.gov/pubmed/31325559,31325559,,
277,528189,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,4744,NEFH,https://ctdbase.org/detail.go?type=gene&acc=4744,,,4744,NEFH,10116,Rattus norvegicus (Norway rat),Cycloheximide results in decreased expression of NEFH mRNA,,,PMID:19146868,https://www.ncbi.nlm.nih.gov/pubmed/19146868,19146868,,
278,525564,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,224893,ZFP959,https://ctdbase.org/detail.go?type=gene&acc=224893,,,224893,Zfp959,10090,Mus musculus (house mouse),Methylene chloride results in increased expression of ZFP959 mRNA,,,PMID:28392392,https://www.ncbi.nlm.nih.gov/pubmed/28392392,28392392,,
279,525565,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,112422,ZFP979,https://ctdbase.org/detail.go?type=gene&acc=112422,,,112422,Zfp979,10090,Mus musculus (house mouse),Methylene chloride results in decreased expression of ZFP979 mRNA,,,PMID:28392392,https://www.ncbi.nlm.nih.gov/pubmed/28392392,28392392,,
280,525566,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,11244,ZHX1,https://ctdbase.org/detail.go?type=gene&acc=11244,,,11244,ZHX1,10090,Mus musculus (house mouse),Methylene chloride affects the expression of ZHX1 mrna|methylene chloride results in increased expression of ZHX1 mRNA,,,PMID:28392392,https://www.ncbi.nlm.nih.gov/pubmed/28392392,28392392,,
281,525567,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,84460,ZMAT1,https://ctdbase.org/detail.go?type=gene&acc=84460,,,84460,ZMAT1,10090,Mus musculus (house mouse),Methylene chloride results in increased expression of ZMAT1 mRNA,,,PMID:28392392,https://www.ncbi.nlm.nih.gov/pubmed/28392392,28392392,,
282,525568,6344,Comparative Toxicogenomics Database (CTD),Methylene Chloride,D008752,Methylene Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008752,9753,ZSCAN12,https://ctdbase.org/detail.go?type=gene&acc=9753,,,9753,ZSCAN12,10090,Mus musculus (house mouse),Methylene chloride results in decreased expression of ZSCAN12 mRNA,,,PMID:28392392,https://www.ncbi.nlm.nih.gov/pubmed/28392392,28392392,,
283,525569,6354,Comparative Toxicogenomics Database (CTD),Ethylene Oxide,D005027,Ethylene Oxide,https://ctdbase.org/detail.go?type=chem&acc=D005027,328,APEX1,https://ctdbase.org/detail.go?type=gene&acc=328,,,328,APEX1,10116,Rattus norvegicus (Norway rat),Ethylene oxide results in increased expression of APEX1 protein,,,PMID:16051529,https://www.ncbi.nlm.nih.gov/pubmed/16051529,16051529,,
284,525570,6354,Comparative Toxicogenomics Database (CTD),Ethylene Oxide,D005027,Ethylene Oxide,https://ctdbase.org/detail.go?type=chem&acc=D005027,649,BMP1,https://ctdbase.org/detail.go?type=gene&acc=649,,,649,BMP1,9870,Rangifer tarandus (reindeer),Ethylene oxide results in decreased activity of BMP1 protein,,,PMID:15224167,https://www.ncbi.nlm.nih.gov/pubmed/15224167,15224167,,
285,525571,6354,Comparative Toxicogenomics Database (CTD),Ethylene Oxide,D005027,Ethylene Oxide,https://ctdbase.org/detail.go?type=chem&acc=D005027,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),Ethylene oxide analog affects the activity of CASP3 protein,,,PMID:16311010,https://www.ncbi.nlm.nih.gov/pubmed/16311010,16311010,,
286,525572,6354,Comparative Toxicogenomics Database (CTD),Ethylene Oxide,D005027,Ethylene Oxide,https://ctdbase.org/detail.go?type=chem&acc=D005027,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571,CYP2E1,10090,Mus musculus (house mouse),[CYP2E1 protein results in increased metabolism of ethylene] which results in increased abundance of ethylene oxide,,,PMID:21785163,https://www.ncbi.nlm.nih.gov/pubmed/21785163,21785163,,
287,501075,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23536,ADAT1,https://ctdbase.org/detail.go?type=gene&acc=23536,,,23536,ADAT1,90988,Pimephales promelas (fathead minnow),Bisphenol A affects the expression of ADAT1 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
288,527538,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23014,FBXO21,https://ctdbase.org/detail.go?type=gene&acc=23014,,,23014,FBXO21,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of FBXO21 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
289,527539,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26263,FBXO22,https://ctdbase.org/detail.go?type=gene&acc=26263,,,26263,FBXO22,7955,Danio rerio (zebrafish),Bisphenol A affects the expression of FBXO22 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
290,527540,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26263,FBXO22,https://ctdbase.org/detail.go?type=gene&acc=26263,,,26263,FBXO22,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of FBXO22 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
291,527541,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26263,FBXO22,https://ctdbase.org/detail.go?type=gene&acc=26263,,,26263,FBXO22,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of FBXO22 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
292,527542,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26261,FBXO24,https://ctdbase.org/detail.go?type=gene&acc=26261,,,26261,FBXO24,9606,Homo sapiens (human),Bisphenol A results in decreased expression of FBXO24 mRNA,,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
293,527543,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26261,FBXO24,https://ctdbase.org/detail.go?type=gene&acc=26261,,,26261,FBXO24,9940,Ovis aries (sheep),Bisphenol A results in increased expression of FBXO24 mRNA,,,PMID:32417515,https://www.ncbi.nlm.nih.gov/pubmed/32417515,32417515,,
294,527544,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26261,FBXO24,https://ctdbase.org/detail.go?type=gene&acc=26261,,,26261,FBXO24,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FBXO24 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
295,527545,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26261,FBXO24,https://ctdbase.org/detail.go?type=gene&acc=26261,,,26261,FBXO24,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of FBXO24 mRNA,,,PMID:30816183|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016,30816183|32528016,,
296,528324,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,26272,FBXO4,https://ctdbase.org/detail.go?type=gene&acc=26272,,,26272,FBXO4,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of FBXO4 mRNA,,,PMID:34585602,https://www.ncbi.nlm.nih.gov/pubmed/34585602,34585602,,
297,983422,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4337,MOCS1,https://ctdbase.org/detail.go?type=gene&acc=4337,,,4337,MOCS1,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in increased expression of MOCS1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
298,983923,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,440193,CCDC88C,https://ctdbase.org/detail.go?type=gene&acc=440193,,,440193,CCDC88C,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of CCDC88C mRNA,,,PMID:21570461,https://www.ncbi.nlm.nih.gov/pubmed/21570461,21570461,,
299,983924,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,440193,CCDC88C,https://ctdbase.org/detail.go?type=gene&acc=440193,,,440193,CCDC88C,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of CCDC88C mRNA,,,PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/34747641,34747641,,
300,983925,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,220388,CCDC89,https://ctdbase.org/detail.go?type=gene&acc=220388,,,220388,CCDC89,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of CCDC89 mRNA,,,PMID:26377647,https://www.ncbi.nlm.nih.gov/pubmed/26377647,26377647,,
301,983926,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,26093,CCDC9,https://ctdbase.org/detail.go?type=gene&acc=26093,,,26093,CCDC9,9606,Homo sapiens (human),Tetrachlorodibenzodioxin affects the expression of CCDC9 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
302,1403762,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9681,DEPDC5,https://ctdbase.org/detail.go?type=gene&acc=9681,,,9681,DEPDC5,10090,Mus musculus (house mouse),Triptonide affects the expression of DEPDC5 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
303,1403763,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,64798,DEPTOR,https://ctdbase.org/detail.go?type=gene&acc=64798,,,64798,DEPTOR,10090,Mus musculus (house mouse),Triptonide results in decreased expression of DEPTOR mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
304,1594772,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,4621,MYH3,https://ctdbase.org/detail.go?type=gene&acc=4621,,,4621,MYH3,9606,Homo sapiens (human),Cannabidiol results in increased expression of MYH3 protein,,,PMID:34122009,https://www.ncbi.nlm.nih.gov/pubmed/34122009,34122009,,
